Empagliflozin reduced risk of death and hospitalisation for heart failure by 25 per cent in adults Read more
CARE consortium launched to fast-track discovery and development of medicines to treat COVID-19 Read more
Boehringer Ingelheim expands animal health portfolio in India market with two new drugs launches Read more
Cipla continues to expand focus on therapy areas of promising growth through deals: GlobalData Read more
Linagliptin demonstrates cardiovascular and renal safety in Asian adults with type 2 diabetes Read more
DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease Read more
Boehringer Ingelheim and CDR-Life to develop Antibody Fragment-based Therapeutics for Geographic Atrophy Read more